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Abstract:  
Due to dramatic improvements in life expectancy we are seeing a rapidly growing population of 
older people. Increasing frailty and susceptibility to fragility fractures are becoming pressing issues 
for both the individuals that suffer them as well as society, through pressures on health and social 
care budgets. The success of fracture liaison services, co-ordinated programmes enhancing the 
management of the fracture, osteoporosis, frailty and falls risk, is undisputed. To achieve optimal 
outcomes, however, it is important to have a standardisation of design, scope and structure of the 
service. Experience has taught us that by delegating responsibility for the holistic care of the patient 
to a trained and adequately resourced professional/team (fracture prevention practitioner) with 
clear standards against which benchmarking occurs, is the optimal model of delivery. Future 
challenges include how best to measure the success of services in imparting a reduction in fractures 
at a local population level as well as how to detect those patients with unmet need who do not 
uniformly present to health care services, such as those with vertebral fractures. The 
implementation of fracture liaison services however, is a clear demonstration of how collaboration 
between health care, social care and charity organisations, among others, has materially improved 
the health and well-being of the population. 
  
Introduction 
Medical and societal changes mean that people are living longer. With increasing age, however, 
come the risks of frailty that can express themselves in many ways, including an increased tendency 
to fall and fracture. Even with relatively minor trauma, fractures may ensue, fragility fractures that 
can have catastrophic consequences to the individual through attendant mortality and morbidity. 
Furthermore, in addition to the personal costs of such fractures, the societal and economic impact of 
fragility fractures is increasingly evident in the growing older frail cohort. Loss of independence and 
reliance on the state for care and support as well as the direct health care costs of fragility fractures 
has spurred global interest to innovate and effectively prevent fragility fractures through introducing 
models of clinical service that identify those at risk and then effectively intervene to prevent 
subsequent fractures – fracture liaison services (FLS).  
 
Fragility fractures are defined as fractures occurring as a result of a fall from standing height or less. 
They primarily affect older people in whom osteoporosis and increased risk of falls are contributory 
factors1. Morbidity and mortality is significant; in England 1 in 4 people die within a year of suffering 
a hip fracture, with a doubling in the standardised mortality ratio in the first year2,3. In those who 
survive, there are far reaching, long-term consequences and complications such as loss of 
confidence and independence, which can also have a negative impact upon those providing a caring 
role. 
 
Fracture prevention programmes have evolved over the last two decades and have taken many 
shapes, mostly targeting those presenting with their first fracture. Early strategies attempted to 
identify patients and convey patient-focused (or sometimes GP-focused) written material regarding 
fracture prevention; such strategies did not result in large scale treatment uptake with no clear 
evidence of significant change in incidence of fractures. However, more sophisticated and highly 
effective fracture prevention programmes, such as FLS, assess patients through clinical interactions 
that instigate all necessary investigations, referrals and treatment with longer term follow up to 
ensure adherence. Adopting these more sophisticated fracture prevention models (through FLS, see 
figure 1) can reduce hip fracture and refracture rates by more than a third4,5. This review focuses on 
some of the lessons learnt when developing FLS to prevent fragility fractures. 
 
When to intervene: primary versus secondary prevention 
Increasing bone fragility and frailty plus the accumulation of other factors including co-morbidities, 
polypharmacy and sarcopenia predispose towards injury in the form of fragility fractures6,7,8,9. 
Though primary prevention is appealing, and there is growing interest in screening for 
osteoporosis10, the focus of this review is on secondary fracture prevention that identifies at risk 
individuals on the basis of them having sustained a new incident fragility fracture – as such, many 
services are co-located within fracture clinics, working alongside trauma teams as part of an 
integrated acute care and prevention team.  
 
Almost half of patients presenting with a hip fracture have had a previous non-hip fragility fracture11, 
suggesting that that there is an opportunity to intervene with effective osteoporosis treatment in 
order to reduce the likelihood of an ensuing hip fracture. Those with an incident fragility fracture 
thus represent a high risk population where interventions such as bone active medical treatments 
(such as bisphosphonates) and falls interventions are justified12. Patients who are provided with 
appropriate contextualised advice and information at the time of the fracture are likely to be more 
amenable to commencing therapy to mitigate further fractures. Also, the ‘inconvenience’ of being 
immobilised during the treatment of the incident fracture may mean that patients are more likely to 
be receptive to interventions to reduce the likelihood of future events.  
 
There are robust data for bisphosphate prescribing in the setting of secondary fracture prevention 
with increasing cost effectiveness with increasing age and prior fracture13. This approach to 
secondary fracture prevention is supported by NICE, also recommending a multi-disciplinary hip 
fracture programme, e.g. a FLS (see figure 1), due to their well-established success14,15. At the core of 
a FLS is a fracture prevention practitioner (FPP) who co-ordinates secondary fracture prevention 
interventions for an individual with the intention to standardise high quality care and facilitate 
communication between the patient and health care and social care providers.  
 
How to intervene: the optimum model? 
What is the optimal service model to reduce fragility fractures? Fracture prevention programs have 
varied in design and structure but one trend has appeared, namely that a clinician (FPP) must have 
key responsibility for managing both fractures and falls risk in order to be maximally effective. 
Suggestive evidence for this is that simple dissemination of written education leaflets directed to the 
physician and/or patient (without a direct clinical interaction) has demonstrated no significant 
effects on refracture rates nor an increase in appropriate bone density scan (DXA) referrals16. A 
service that is limited to letters to primary care physicians to request prescribing results in low rates 
of bisphosphonate prescription17. With more sophisticated clinical interactions via FPPs, appropriate 
DXA referrals and bisphosphonate prescribing is increased in addition to more effective completion 
of a comprehensive falls risk and fracture assessment18.  
 
Although the majority of FLS are run within a secondary care environment, some community-based 
programmes operate, although attendance for subsequent DXA scanning appointments in these 
models may be as low as 45%19. By delegating responsibility for components of the FLS to non-
specialised staff (for example GPs) without specific and designated resources, delay and variation in 
practice is introduced and efficacy may be compromised, as evidenced by failure of education only 
programmes14. A meta-analysis examining the collaboration of orthopaedic teams with an 
orthogeriatrician has proven reduction in mortality demonstrating the benefit of expanding care 
beyond purely fracture fixation20. FPPs who are not medically trained, e.g. nurses, have been a 
successful alternative to physicians as primary healthcare professionals21. Adequate resources, 
education and training however must be in place with standard competencies ranging from beginner 
to expert22. Completion of accredited FPP training not only supports and informs the individual but is 
auditable according to clinical standards and should result, if put into practice, in improved clinical 
outcomes22,23. In order to work effectively there should be access to investigations and specialist 
advice and, most importantly, orthopaedic engagement, with FLS embedded within fracture 
clinic/services.  
 
It is important to establish ‘what good looks like’ in terms of delivering an effective FLS model of 
care. UK national clinical standards for FLS have been published by the National Osteoporosis Society 
(NOS) that provide ten clear, practical and deliverable parameters that define a high quality FLS. The 
5IQ model has been widely adopted describing standards for identification and investigation of the 
patients followed by providing information to the patient and appropriate interventions (bone 
protection and falls prevention) (figure 2)23. Finally, integration of care by sharing information with 
patient and primary care and follow up of the patient once discharged to the community to ensure 
interventions are initiated and adhered to by the GP and patient alike is mandated. This is essential 
to realise the fracture prevention benefits of the treatment. The Q represents quality, and quality 
assurance as well as on-going training of staff, is recommended as part of the service model. We 
have shown that it is feasible and practical to deliver the indicators within the 5IQ model (figure 2)24. 
 
As the evidence base behind bone fragility, fracture susceptibility and osteoporosis has developed, 
there has been a more sophisticated approach to fracture prevention within FLS compared with 
early BMD only-based models. FLSs should provide a holistic management of the patient to include 
an assessment of falls risk as well as bone health. The scope of FLS should also include 
referrals/signposting to other services including optometry, podiatry, alcohol and smoking cessation, 
social care, rapid response and home safety services, physiotherapy, occupational therapy and third 
sector organisations (charity and self-help groups) and for Holter monitors. By using and then 
studying social prescribing, patient and carer voices can be integrated, promoting collaboration with 
rehabilitation and care services. The untapped expertise of other organisations, already providing 
services that would benefit those suffering from falls and fractures can be incorporated. If social 
prescribing is readily available and used, it can modify services driven by real data e.g. large numbers 
referred to an exercise class or for home safety assessment. If capacity is exceeded resources can 
therefore be redirected to fulfil the unmet need.  
 
Loss to follow up to allied services, such as mentioned above, is reduced by direct referral from the 
FLS; this also enhances efficiency of the service by reducing the number of steps required. A detailed 
assessment by an individual trained to provide holistic bone health and falls review can produce a 
management plan individualised to the patient, balancing medical and social needs with patient 
preference. Therefore a FLS offering holistic care beyond just medications in a prompt fashion has 
considerable benefits and better patient adherence as well as being well received by orthopaedic 
teams. This has been shown to reduce the likelihood of further injury at a stage of vulnerability and 
high risk of further injuries14. This model may also reduce hospital admissions however further 
investigation of patient outcomes need to take place to fully quantify this. The FLS should also 
promote independence and reduce expenditure in social care through prevention, particularly of hip 
fractures. The NOS estimates that around half of the estimated financial benefit of prevented 
fractures is realised in social care budgets25.  Ref NOS Benefits Calculator online. 
 
Fracture liaison service interventions – making them happen and demonstrating it 
Comment [s1]: reference 
Translating a service model from a theoretical framework to an operational service to benefit 
patients is essential. Those responsible for funding FLS demand demonstration of effectiveness and 
compliance with clinically relevant key performance indicators. Clinically assured quality standards 
that are monitored provide a means for this quality assurance. In addition to the NOS 5IQ standards 
mentioned above, standards have been written by many other organisations23,26,27,28,29. Recording 
workload and performing benchmarking informs commissioning; drives service development; 
illuminates discrepancies in care, e.g. only 37% of services had a FLS in the UK in 2010 (see Table 1 
for examples of service improvement); and highlights those services performing well whose best 
practice can be shared30. Various organisations have set up databases and audits to benchmark and 
drive improvements. A good example is the Royal College of Physicians Falls and Fragility Fracture 
Audit Programme, which audits and publishes hip fracture care against a national quality standard 
(QS16)31,32. 
 
Benchmarking and cost effectiveness analyses have provided the impetus to influence the 
commissioning agenda. For example, the NHS Right-Care programme, developed to reduce 
‘unwarranted variation’, has examined the impact of suboptimal and ideal care, demonstrating a 
91% reduction in health care costs in one case in addition to the improved outcome by an holistic 
approach to fracture management33. By incorporating the FLS clinical standards into the National Hip 
Fracture Database (NHFD) this should help orthopaedic services embrace these standards as 
publication of performance dashboards drives improvements in the system34. Interestingly, through 
national audit programmes, non-evidence based and partial services have been identified. The 
reasons for this degree are complex with shared responsibility shared across commissioner provider 
functions. Certainly there are examples of poorly-informed commissioning decisions but poor 
delivery (which can be shown by auditing against published standards) can lead to waste and 
potential dilution of the benefits of a well commissioned FLS35. The FLS Implementation Toolkit was 
developed by the NOS to aid departments with drafting service specifications and business cases 
conforming to best practice guidelines and current evidence base36. 
 
It is clear, from any change model, that stakeholder engagement is key to achieving successful and 
widespread uptake of (FLS) programmes. The improvements wrought in fracture care and 
prevention are at least in part due to coordination between a range of agencies such as government 
agencies, health care organisations and in fact this has been led by charities to ensure collaborative 
working to improve care. Good examples within the UK are the Royal College of Physicians with the 
NHFD and FLS database and the NOS with its FLS implementation group and clinical champions31,37. 
 
Future of Fragility fracture intervention: challenges and successes 
FLS have been successful; they do reduce recurrent fractures, but data vary depending on the design 
of the FLS14,38. An FLS, in addition, can facilitate a seamless journey for the patient between surgical 
and medical care whilst admitted and continue, or instigate, treatment for those within the 
community. Moving services out of acute hospitals has been on the NHS agenda for years and a well-
designed FLS can promote this agenda through robust communication of plans to community 
partners and remote follow up such as telephone consultations. 
 
The financial case for FLS is premised on reducing fragility fractures in a population. The evidence for 
effectiveness in treated versus untreated cohorts is strong but demonstrating it in a registered or 
resident population presents a challenge38,39. The NHS Right Care metric is the incidence of hip 
fractures in patients ≥60 years. These represent only around 20% of total fragility fractures and there 
is substantial variation from year to year even in populations of several million40,41. Detecting the 
important but modest percentage reduction from an effective FLS and showing this with statistical 
significance within the required time horizon of 1-3 years is not possible. As an alternative, the NOS 
has looked at the number of patients on bone sparing medication per 1000 population over 50 years 
of age as a useful proxy measure. This metric can show statistically significant change within a few 
months of introducing a de novo, or further developed, FLS. 
 
Another challenge faced is the identification of vertebral fractures, commonly missed on x-ray, 
usually diagnostic of osteoporosis, and with a low rate of presentation to health care services, 
particularly if occurring in isolation42,43. Additional views in dual energy X-ray absorptiometry (DXA, 
bone density scans) protocols such as use of vertebral fracture assessment (VFA), could help 
detection if primary prevention models are widely instigated44,45. Other techniques exist such as CT 
scan, MRI and algorithm-based reporting for example but the optimal method is still debated46. 
Research is underway examining how best to reduce the ‘treatment gap’ by identifying those at 
highest risk of fracture who will benefit most from intervention not currently being treated e.g. 
vertebral fractures and primary prevention47.  
 
The ability to do more good by addressing the primary prevention population is clear but the most 
clinical and cost effective method is still debated. Incorporating assessment of sarcopenia as well as 
BMD (e.g. FRAX®) and falls assessment may be the optimal model but further research is required48. 
If the UK GP contract identifies the measurement of frailty in over 65s as a priority, this could 
improve care and reduce injuries as well as providing vital data to support service development and 
commissioning49. With Sustainability and Transformation Plans (STPs) active in UK planning of health 
and social care, FLS are optimally placed to identify those patients who have complex needs and co-
morbidities to intervene to reduce injuries, fractures and attendant disabilities. There are clear 
whole system benefits available from identifying this cohort of patients as they have an associated 
high health resource requirement. 
 
To conclude, implementation of FLS across the UK and globally is increasing although by no means is 
there universal coverage. There is growing awareness that FLS is becoming a ‘standard of care’ and 
not an optional extra. To ensure maximum benefit to patients and payers alike, it is important that 
the model of FLS delivery addresses appropriate clinical quality standards and metrics. There is more 
work to do in terms of identification of vertebral fractures. Probably the most powerful lesson 
learned from developing FLS is the value of effective partnership working between charitable 
organisations, healthcare professionals and government bodies. This collaborative working has 
allowed rapid development and implementation of FLS, addressing the varying agendas and needs of 
patients, health care providers, commissioners and health and social care planners.  
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Figure 1: Diagram to represent role of fracture liaison service in secondary fracture prevention. A 
person, or team, known as a fracture prevention practitioner co-ordinates holistic assessment and 
management of fragility fractures within a healthcare setting but collaborating with patient and 
other essential organisations.  
Or Figure 1: National Osteoporosis Society’s example of generic fracture liaison service. 
 
Figure 2: Diagrammatic representation of National Osteoporosis Society fragility fracture 
management 5IQ standards for a fracture liaison service. 
 
Table 1: Service improvements for FLS over the last 2 years (2015-2017); NOS in house data. 
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 England Northern 
Ireland & 
Isle of Man 
Scotland Wales UK 
New service 
development 59 1 2 7 69 
Quality improvement; 
commissioning 33 5 1 1 40 
Quality improvement; 
peer support 23 1 12 6 42 
Early engagement 22 0 1 2 25 
Sub-total 137 7 16 16 176 
Commissioning 
New services 13 0 1 3 17 
Existing service 
enhanced 6 0 0 0 6 
Sub-total 19 0 1 3 23 
Benefits 
Total population 
covered 4,201,867  300,410 962,188 5,464,465 
Hip fractures 
prevented* 1,482  102 348 1,932 
Gross benefit of all 
fractures prevented 
(£)* 
29,841,500  1,995,006 6,772,362 38,608,868 
*Over 5 years. Figures based on 17 new services NOS has helped commission. 
